Simple Therapies Boost Heart Attack Survival
Mukherjee believes the Swedish research could yield similar results in the U.S.
According to research recently published in the Journal of the American Medical Association and an accompanying commentary by Debabrata Mukherjee, M.D., chief of cardiovascular medicine at the Paul L. Foster School of Medicine, the increased use of evidence-based treatments for heart attacks like rapid angioplasty has led to a decrease in deaths from heart attacks.
Cardiovascular disease remains the most common cause of morbidity and mortality in the U.S.
In the study, Thomas Jernberg of the Karolinska Institute in Stockholm and his colleagues used data from a Swedish registry on more than 61,000 patients who experienced a deadly heart attack known as STEMI between 1996 and 2007.
“The combined use of simple therapies such as aspirin and cholesterol-lowering medications and balloon stents were associated with a significant reduction in mortality,” Mukherjee said. “We would expect to have similar findings in the United States.”
Read the full story from Reuters >>
Related
PAP Smears: What, Why and When
Related Stories
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
TTUHSC Names New Regional Dean for the School of Nursing
Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.
Recent Stories
Abid Brings Hematology Expertise to TTUHSC Oncology Team
Muhammad Bilal Abid, M.D., has joined the TTUHSC School of Medicine oncology team as an associate professor of internal medicine and medical director of TTUHSC’s Blood and Marrow Transplantation & Cellular Therapy Program.
Research Team Studies Cardiovascular Disease Risk in Homeless Population
A team of student researchers from TTUHSC and TTU evaluated differences in CVD risk between men and women experiencing poverty and homelessness in West Texas, a medically underserved region within the TTUHSC service area.
Clinical Trials Provide Access to Latest Cancer Interventions
Beginning in 2008, TTUHSC, through the School of Medicine Pediatric Cancer Research Center in 2025, has conducted multiple phase 1 oncology clinical trials for pediatric and adult cancer patients. These trials will pave new ground for patients now and in the future.